Skip to content
Mandala International
  • Home
  • About Us
  • Services
  • Market
    • Brazil
    • Mexico
    • Colombia
    • Peru
    • LATAM Expansion Pack
  • Blog
  • Contact Us
Mandala International
  • Blog
  • Brazil
  • Colombia
  • Home
  • LATAM Expansion Pack
  • Mexico
  • Peru

[Chile] MINSAL enhances oversight for Medical Devices and IVDs 

Date: March 19h, 2026 The Chilean Ministry of Health (MINSAL) has recently published Exempt Decree No. 25, setting up a new health control regime for a wide range of medical devices (MD) and in vitro […]

[Chile] MINSAL enhances oversight for Medical Devices and IVDs  Read More »

[Mexico] Streamlined regulations and enhanced safety for medical imports in Mexico

Date: January 17th, 2026 The Mexican government officially updated the General Health Law, specifically Article 376. These changes are designed

[Mexico] Streamlined regulations and enhanced safety for medical imports in Mexico Read More »

Aligning regulatory compliance with commercial performance in Latin America

In the traditional corporate hierarchy, the regulatory affairs department and the commercial sales team have often been viewed as polar opposites.

Aligning regulatory compliance with commercial performance in Latin America Read More »

How to build a market entry strategy for regulated health products

How to build a market entry strategy for regulated health products in Latin America ?

Expanding into international markets with regulated health products, including medical devices, pharmaceuticals, food supplements, cosmetics, sanitizers, and veterinary products, requires more than identifying commercial opportunities. Companies

How to build a market entry strategy for regulated health products in Latin America ? Read More »

[Mexico] Mexico fast-track medical device registration now operational: 30-day COFEPRIS pathway

Date: March 4, 2026 Mexico has begun operational implementation of its fast-track pathway for medical device registration, allowing eligible products

[Mexico] Mexico fast-track medical device registration now operational: 30-day COFEPRIS pathway Read More »

Health regulatory authorities in Latam : pratical guide

Health regulatory authorities in Latin America: A country-by-country guide for market access

Understanding health regulatory authorities in Latin America is essential for manufacturers of medical devices, pharmaceuticals, food supplements, cosmetics, sanitizers, and

Health regulatory authorities in Latin America: A country-by-country guide for market access Read More »

[Brazil] ANVISA publishes UDI database rules (IN N°426/2026)

Date: February 18, 2026 The ANVISA has published Normative Instruction (IN) No. 426/2026, establishing the requirements for transmission and management

[Brazil] ANVISA publishes UDI database rules (IN N°426/2026) Read More »

[Brazil] ANVISA publishes new cannabis regulation (RDC N° 1.015/2026)

Date: February 5, 2026 The ANVISA has published RDC No. 1.015/2026, revising and updating the regulatory framework for granting sanitary

[Brazil] ANVISA publishes new cannabis regulation (RDC N° 1.015/2026) Read More »

[Brazil] ANVISA updates reliance authority list (IN No. 403/2025)

Date: November 12, 2025 The ANVISA has updated its list of Equivalent Foreign Regulatory Authorities (AREEs) through the publication of

[Brazil] ANVISA updates reliance authority list (IN No. 403/2025) Read More »

[Brazil] ANVISA regulates nasal saline solutions as Medical Devices

Date: November 3, 2025 The ANVISA has approved a new regulation classifying sodium chloride-based products intended for nasal irrigation as medical

[Brazil] ANVISA regulates nasal saline solutions as Medical Devices Read More »

[Brazil] Ozone therapy authorized for specific medical treatments in Brazil

Date: October 29, 2025 The Federal Council of Medicine (CFM) has officially authorized the use of ozone therapy for specific

[Brazil] Ozone therapy authorized for specific medical treatments in Brazil Read More »

[Brazil] ANVISA announces progress in its modernization plan and reinforces commitment to reducing backlogs

ANVISA presented the latest results of its Strengthening and Modernization Plan during a meeting of the Executive Group of the

[Brazil] ANVISA announces progress in its modernization plan and reinforces commitment to reducing backlogs Read More »

Copyright © 2026 Mandala International | Powered by Astra WordPress Theme